1313426-10-6 Usage
Explanation
This compound is classified as a fluorinated aromatic compound because it contains a benzene ring with fluorine atoms attached to it.
3. Bromine atom
Explanation
The presence of a bromine atom (Br) in the molecule contributes to its unique chemical properties and potential applications.
4. 1,1-difluoroethyl group
Explanation
The 1,1-difluoroethyl group is a functional group consisting of two fluorine atoms attached to an ethyl group. This group is attached to the benzene ring, further modifying the compound's properties.
5. Organic synthesis and pharmaceutical research
Explanation
1-bromo-3-(1,1-difluoroethyl)-2-fluorobenzene is commonly used in these fields due to its unique chemical properties, making it a valuable building block for creating more complex organic molecules and pharmaceutical compounds.
6. Building block for complex molecules
Explanation
This compound serves as a starting point for the synthesis of more complex organic molecules, which can be used in various applications, including pharmaceuticals and materials science.
7. Health and environmental risks
Explanation
Proper handling, management, and disposal of this compound are essential to minimize potential health and environmental risks associated with its use.
8. Caution required
Explanation
Due to the potential risks associated with this compound, it is crucial to follow safety protocols and guidelines when working with it to ensure the safety of both the user and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1313426-10-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,3,4,2 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1313426-10:
(9*1)+(8*3)+(7*1)+(6*3)+(5*4)+(4*2)+(3*6)+(2*1)+(1*0)=106
106 % 10 = 6
So 1313426-10-6 is a valid CAS Registry Number.
1313426-10-6Relevant articles and documents
SUBSTITUTED TRICYCLIC COMPOUNDS
-
Page/Page column 106, (2021/07/02)
Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, wherein, ring A, ring B, R1 to R4, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.
